US Stock MarketDetailed Quotes
MYNZ Mainz Biomed
- 0.277
- +0.062+28.70%
Close Nov 12 16:00 ET
- 0.283
- +0.006+2.24%
Post 18:58 ET
7.08MMarket Cap-249P/E (TTM)
0.360High0.223Low51.19MVolume0.249Open0.215Pre Close14.60MTurnover231.74%Turnover RatioLossP/E (Static)25.59MShares1.79052wk High-1.71P/B6.11MFloat Cap0.18552wk Low--Dividend TTM22.09MShs Float30.000Historical High--Div YieldTTM63.58%Amplitude0.185Historical Low0.285Avg Price1Lot Size
About Mainz Biomed Company
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Company Profile
SymbolMYNZ
Company NameMainz Biomed
Listing DateNov 5, 2021
Issue Price5.00
Founded2021
CEOMr. Guido Baechler
MarketNASDAQ
Employees71
Fiscal Year Ends12-31
AddressSirius Gutenberg Park,Robert Koch Strasse 50
CityMainz
ProvinceRheinland-Pfalz
CountryGermany
Zip Code55129
Phone49-6131-55428-60
Websitehttp://mainzbiomed.com
Company Executives
- Name
- Position
- Salary
- Guido Baechler
- Chief Executive Officer and Director
- --
- Dr. Moritz Eidens
- Chief Scientific Officer and Director
- --
- Dr. Frank Krieg-Schneider
- Chief Technology Officer
- --
- William J. Caragol
- Chief Financial Officer
- --
- Philipp Freese
- Chief Business Officer
- --
- Darin Leigh
- Chief Commercial Officer
- --
- Dr. Chris von Toerne
- Chief Operating Officer
- --
- Dr. Heiner Dreismann,PhD
- Independent Director
- --
- Dr. Alberto Libanori, PhD
- Independent Director
- --
- Hans Hekland
- Independent Director
- --
- Gregory J. Tibbitts
- Independent Director
- --
- Nicole Holden
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data